Migrén: vizsgálatok itt: Izrael
5 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleA Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
- Where
- Jerusalem, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Pfizer
See details and how to joinNCT07609914 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
- Where
- Jerusalem, Tel Aviv
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Pfizer
See details and how to joinNCT07729462 · EU 2026-525295-25-00 - 3. fázisTaking peopleA Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Where
- Beer Ya'akov, Hadera, Haifa, Ramat Gan, Tel Aviv
- Életkor
- 6 év to 17 év
- People
- 450 worldwide
- Run by
- AbbVie
See details and how to joinNCT05711394 · EU 2022-501100-94-00 - No phaseTaking peopleThe Effect of Remote Electrical Neuromodulation (REN) on Conditioned Pain Modulation (CPM) in Migraine and Fibromyalgia
- Where
- Haifa
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Theranica
See details and how to joinNCT07841509 - 3. fázisCsak meghívásosLong-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
- Where
- Beer Ya'akov, Hadera, Haifa, Ramat Gan, Tel Aviv
- Életkor
- 6 év to 17 év
- People
- 650 worldwide
- Run by
- AbbVie
See details and how to joinNCT05707949 · EU 2022-501099-24-00